Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide | 1266212-81-0 | 98.0% | 480.99 | C26H29ClN4O3 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY10008050MG

Encompass_Preferred

A-887826 is a potent, selective, voltage-dependent Nav1.8 (NaV1.8) sodium channel blocker described in peer-reviewed literature. It inhibits recombinant human Nav1.8 channels with an IC50 of approximately 11 nM, is orally bioavailable in preclinical models, and attenuates neuropathic tactile allodynia. It is provided as a research-grade solid for preclinical pharmacology studies.

  • Potent Nav1.8 inhibition with IC50 ~11 nM.
  • Selective, voltage-dependent mechanism of action.
  • Demonstrated oral bioavailability in preclinical studies.
  • Reduces neuropathic tactile allodynia in animal models.
  • Supplied as research-grade powder with typical purity of 98.0%.
  • Chemical formula C26H29ClN4O3; molecular weight 480.99.

Catalog No. 50-002-15722


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.